Unknown

Dataset Information

Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis.


ABSTRACT: Importance/Background: The coronavirus disease (COVID-19) pandemic is a critical public health issue. Evidence has shown that metformin favorably influences COVID-19 outcomes. This study aimed to assess the benefits and risks of metformin in COVID-19 patients. Methods: We searched the PubMed, Embase, Cochrane Library, and Chinese Biomedical Literature Database from inception to February 18, 2021. Observational studies assessing the association between metformin use and the outcomes of COVID-19 patients were included. The primary outcome was mortality, and the secondary outcomes included intubation, deterioration, and hospitalization. Random-effects weighted models were used to pool the specific effect sizes. Subgroup analyses were conducted by stratifying the meta-analysis by

SUBMITTER: Li Y 

PROVIDER: S-EPMC8416892 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature